CBRE Group, Inc.
CBRE · NYSE
Analyst ratings
strong_buy · 6 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| June 30, 2026 | Evercore ISI Group | Maintains | Outperform | $169.00 |
| May 5, 2026 | Barclays | Maintains | Overweight | $178.00 |
| April 24, 2026 | Evercore ISI Group | Maintains | Outperform | $179.00 |
| April 24, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $175.00 |
| April 14, 2026 | Barclays | Maintains | Overweight | $175.00 |
| March 13, 2026 | Barclays | Maintains | Overweight | $174.00 |
| February 23, 2026 | UBS | Upgrades | Buy | $185.00 |
| February 13, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $170.00 |
| January 13, 2026 | Barclays | Maintains | Overweight | $192.00 |
| January 8, 2026 | Keefe, Bruyette & Woods | Maintains | Outperform | $192.00 |
| December 15, 2025 | Keefe, Bruyette & Woods | Upgrades | Outperform | $185.00 |
| October 24, 2025 | UBS | Maintains | Neutral | $175.00 |
| October 10, 2025 | UBS | Maintains | Neutral | $165.00 |
| October 9, 2025 | Keefe, Bruyette & Woods | Maintains | Market Perform | $168.00 |
| October 7, 2025 | Morgan Stanley | Maintains | Overweight | $180.00 |
| August 26, 2025 | JP Morgan | Maintains | Overweight | $185.00 |
| August 25, 2025 | Evercore ISI Group | Maintains | Outperform | $185.00 |
AI and data center exposure as a growth catalyst vs. overvalued hype
CBRE's strategic positioning in data centers and digital infrastructure, combined with AI-driven operational efficiencies, is seen as a powerful, durable growth engine. UBS reiterates a Buy with a $185 target, citing AI's role in enhancing CBRE's data advantages and competitive differentiation in a rapidly expanding market.
Despite enthusiasm around AI tailwinds, CBRE's stock has declined 18.2% in 2026 and sits ~24.5% below its 52-week high, suggesting the market is skeptical that AI-related exposure alone can offset broader macroeconomic headwinds and sustain premium valuation levels.
Earnings trajectory and estimate reliability amid macro uncertainty
CBRE delivered a striking Q1 2026 earnings beat, with EPS of $1.61 versus the $1.13 consensus — a 42.48% upside surprise — and raised its FY 2026 guidance to $7.60–$7.80 EPS. Analysts at Raymond James and JPMorgan responded by lifting price targets, reflecting growing conviction in the earnings trajectory.
Despite recent beats, Zacks projects CBRE will miss its next quarterly consensus estimate by nearly 8%, and Weiss Ratings downgraded the stock from Buy to Hold. This signals uncertainty about whether strong quarterly results are sustainable or reflect temporary tailwinds rather than structural improvement.
Stock valuation and the gap between price targets and current market performance
With 13 analysts maintaining a Strong Buy consensus and a mean price target of $180.82 — implying over 37% upside — Wall Street broadly views CBRE as undervalued. InvestingPro's Altman Z-Score of 4.13 and a low debt-to-capital ratio of 21% further support the case for a re-rating higher.
Goldman Sachs recently trimmed its price target from $183 to $178, and Evercore ISI cut its target from $179 to $169, reflecting diminishing near-term confidence. The wide standard deviation of $16.7 across analyst price targets, ranging from $135 to $200, reveals deep disagreement about intrinsic value.